Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,426 | 42,565 | 887 | N/A | N/A |
| Other current assets | 0 | 115 | 0 | 0 | 0 |
| TOTAL | $34,107 | $43,171 | $890 | $2 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,041 | 327 | 4 | 5 | N/A |
| Other Non-Current Assets | 1,244 | 51 | 461 | 0 | 0 |
| TOTAL | $2,285 | $378 | $465 | $5 | $N/A |
| Total Assets | $36,392 | $43,549 | $1,355 | $7 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,017 | 1,604 | 951 | 279 | 0 |
| Accrued Expenses | 3,120 | 3,056 | 1,015 | 52 | N/A |
| Other current liabilities | 331 | N/A | N/A | N/A | N/A |
| TOTAL | $8,468 | $4,660 | $2,337 | $331 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,029 | 0 | 0 | 0 | 0 |
| TOTAL | $1,029 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,497 | $4,660 | $2,337 | $331 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,261 | 979 | N/A | N/A | N/A |
| Common Shares | 18 | 16 | 10 | N/A | N/A |
| Retained earnings | -56,688 | -23,720 | -4,450 | N/A | N/A |
| Other shareholders' equity | 0 | 0 | 0 | -324 | 0 |
| TOTAL | $26,895 | $38,889 | $-982 | $-324 | $N/A |
| Total Liabilities And Equity | $36,392 | $43,549 | $1,355 | $7 | $0 |